Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Ionis Pharmaceuticals, Inc.
Scientific Title
A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)